TOKYO–(BUSINESS WIRE)–Jul 28, 2022– DIC Corporation (TOKYO:4631) introduced the beginning of the second part of a joint improvement settlement with California-based biotech startup Debut Biotechnology, Inc. (Debut Biotech), an artificial biology firm on the forefront of superior biomanufacturing know-how. The settlement focuses on creating pure pink colorants for the meals, vitamin, and cosmetics industries. Debut… Continue reading DIC and Debut Biotech Advance and Scale Biomanufacturing of Sustainable Red Colorants for Food, Nutrition, and Cosmetics | News